These novel drugs , including Wegovy, Mounjaro , and Zaxig , represent a significant advancement in addressing type 2 the condition and promoting weight loss . They function by emulating the body’s natural incretin GLP-1 , enabling to control blood sugar and lower hunger . The therapy has slightl